Anthony Davies
Scientific Advisory Board
CellGenix
Germany
Biography
After training as a biochemist, chemical engineer and molecular biologist, Anthony Davies has worked in the cell and gene therapy field for some 20 years. Over this period he has held positions of increasing responsibility at companies including Onyx Pharmaceuticals, Geron Corporation and Capricor. He is now president of Dark Horse Consulting (DHC), a boutique practice focussed on CMC and product development issues in monoclonal antibody, cell and gene therapies. DHC is based in California and has a European office in London – its clients range from academic institutions, through small and mid-sized companies to global pharmaceutical companies.
Research Interest
Cell and gene therapy
